N-(Dibenzo[b,d]furan-3-yl)acetamide

Catalog No.: 
ACMJFU376
CAS No.: 
5834-25-3
Molecular Formula: 
C14H11NO2
Molecular Weight: 
225.25
N-(Dibenzo[b,d]furan-3-yl)acetamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$158.00InquiryInquiry
100mg95%$229.00InquiryInquiry
250mg95%$316.00InquiryInquiry
1g95%$622.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-(Dibenzo[b,d]furan-3-yl)acetamide
IUPAC NameN-(dibenzo[b,d]furan-3-yl)acetamide
MDL No.MFCD00092347
Molecular FormulaC14H11NO2
Molecular Weight225.25
SMILESCC(NC1=CC=C2C(OC3=CC=CC=C23)=C1)=O
InChI KeyLEHHDJYYMLPGOR-UHFFFAOYSA-N
SynonymN-(Dibenzofuran-3-yl)acetamide;2-ACETAMIDODIBENZOFURAN;3-ACETAMIDODIBENZOFURAN;Acetamide, N-3-dibenzofuranyl-;N-{8-oxatricyclo[7.4.0.0,2,7]trideca-1(9),2(7),3,5,10,12-hexaen-5-yl}acetamide;N-3-Dibenzofuranylacetamide
CAS No.5834-25-3

Synthetic Route by SureRoute

1. ACMJFU376 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACTLBX307 route compound structure diagram
    ACTLBX3074106-66-5In Stock
  4. Then
  5. ACMJFU376 route product structure diagram
    ACMJFU3765834-25-3
Inquiry

2. ACMJFU376 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACTLBX307 route compound structure diagram
    ACTLBX3074106-66-5In Stock
  4. Then
  5. ACMJFU376 route product structure diagram
    ACMJFU3765834-25-3
Inquiry

3. ACMJFU376 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACCZIU451 route compound structure diagram
    ACCZIU451563-67-7In Stock
  2. Plus
  3. ACTLBX307 route compound structure diagram
    ACTLBX3074106-66-5In Stock
  4. Then
  5. ACMJFU376 route product structure diagram
    ACMJFU3765834-25-3
Inquiry

Comments (0)